Cardiovascular Pharmacology: Inotropes, Vasopressors and ...
Cardiovascular pharmacology Chapter 32 Antianginal drugs China Medical University.
-
Upload
bathsheba-webb -
Category
Documents
-
view
228 -
download
3
Transcript of Cardiovascular pharmacology Chapter 32 Antianginal drugs China Medical University.
Cardiovascular Cardiovascular pharmacologypharmacology
Chapter 32 Antianginal drugsChapter 32 Antianginal drugs
China Medical University
Angina
Angina is a specific type of pain in the chest caused by inadequate blood flow through the blood vessels (coronary vessels) of the heart muscle (myocardium).
So coronary flow does not meet the metabolic needs of the heart, a radiating chest pain ---anginal pain –results .
The heart as pump
Left anterior descending
CoronaryBlood Flow
Oxygen Supply
Oxygen Demand
Systolic BP
LV Volume
Contractility
Heart Rate
LV Wall Tension
Arrhythmias
Ischemia
LV Dysfunction Chest Pain
pathology
Causes of angina
• Coronary atherosclerosis
• Coronary artery spasm
• Transient platelet aggregation and coronary thrombosis
• Endothelial injury causing the accumulation of vasoconstrictor substances.
• Coronary vasoconstriction following adrenergic stimulation
Stable or classical angina is due to fixed stenosis 狭窄 of the coronary arteries, and is brought on by exercise and stress.
Unstable angina can occur suddenly at rest, and becomes progressively worse, with a increase in the number and severity of attacks.
Variant angina occurs at rest, at the same time each day, and usually due to coronary artery spasm .
Classification of angina :Classification of angina :
• Nitrate esters : Nitroglycerin Isosorbide dinitrate (IDN) 硝酸异山梨酯 receptor blocker : Propranolol Atenolol Metoprolol • Calcium channel blockers: Verapamil Diltiazem Nifedipne Unstable angina is treated with:
• Aspirin (reduces platelet aggregation)
Classifications of treatment medicine
Nitrate esters CH2
CH2
CH
O NO2
O NO2
O NO2
Nitroglycerin 硝酸甘油
CH2 CH CH CH CH CH2
O NO2
O NO2
O
O
CH2 CH CH CH CH CH2
O NO2
O H
O
O
Isosorbide Dinitrate硝酸异山梨酯
Isosorbide -5-Mononitrate5’- 单硝酸异山梨酯
Nitroglycerin 硝酸甘油
Dilatation of the coronary arteries increases blood flow and oxygen delivery to the myocardium.
Pharmacological Function:CH2
CH
CH2
O NO2
O NO2
O NO2
Dilatation of the veins and artery decreases preload and afterload thus the oxygen demand of the heart
Increase the heart rate
Nitroglycerin are prodrugs, decomposing to form nitric oxide (NO), which activates guanylyl cyclase (GC) ,thereby increasing the levels of cyclic guanosine monophosphate (cGMP). Protein kinase G is activated and contractile proteins are phosphorylated.
Mechanism of action:
active
Ca2+ inner cell
VSM dilation
NO
cGMP dependent PK-PKG
SMC or EC ( GC )
cGMP
Nitrate esters
active
Inhibit platelet aggregation and adhesion
Nitroglycerin is administered sublingually , and can be given by intravenous infusion or from patches.
Nitroglycerin is given for the prophylaxis预防 and treatment of angina - Stable angina
Route of administration:
Indication:
The side effects of nitroglycerin include postural hypotension, tachycardia, headache ,flushing and dizziness.
To avoid nitrate tolerance, a drug-free period of approximately 8 hours is needed.
Adverse effects :
Therapeutic notes:
-receptor blocker
• Propranolol 普奈洛尔• Pindolol 吲哚洛尔• Timolol 噻吗洛尔
Metoprolol 美托洛尔
Atenolol 阿替洛尔
Pharmacological Function:
-blockers-blockers block 1- adrenoreceptors in the heart. this causes a decrease in heart rate (slowing of phase 4) in systolic blood pressure in cardiac contractile activity and in myocardial oxygen demand. 1
2) Improve the myocardial metabolism 3) Increases blood flow and oxygen of The ischemia region4) Promote the oxygen release from the Hb
Inhibit platelet aggregation
Clinical utilization:
• Stable or classical angina (specially to patient who concurring the fast heart rate and hypertension )
• Unstable angina not suitable to Variant angina receptor (一) α receptor will be predominate
coronary artery spasm
To
Contraindications and notes
• Related to heart:
Bradycardia, hypotention, AV block, and CHF
• Asthmatic 哮喘
•β1 receptor up-regulation
So slowly reduce the doses
Calcium-channel blockers
Verapamil
Diltiazem
Nifedipine
Examples of calcium-channel blockers include
block L-type calcium channels, thereby reducing calcium entry into cardiac and vascular cells
block L-type calcium channels in vascular cells,
This decrease in intracellular calcium →reduces cardiac contractility and causes vasodilatation, which results in several effects: Reduced preload due to the reduced venous pressure; Reduced afterload due to the reduced arteriolar pressure; Increased coronary blood flow; Reduced cardioc contractility decreased heart rate anti-sympathetic activity
reduced myocardial oxygen consumption
Pharmacological Function:
Coronary vascular dilatation promote the opening of side branch Inhibit platelet aggregation
Increase the supply of blood
Protect the ischemic myocardial
Treatment of angina Variant angina
Verapamil is given for
Clinical uses
supraventricular arrhythmias
othersDipyridamole 双嘧达莫 潘生丁
Nicorandil 尼可地尔
Dipyridamol causes inhibition of adenosine uptake, resulting in the accumulation of adenosine within the tissue.
Adenosine is an endogenous vasodilator---the effect is pronounced on arterioles
Nicorandil increase the cGMP , active the channel of potassium ,dilate the coronary vessels
conjunction use
Nitrate esters + Calcium-channel blockersAmlodipine 氨氯地平 络活喜
-receptor blocker + Calcium-channel blockers
Nitrate esters+ -receptor blocker
N- Nitrate esters B -β -receptor blocker Notes :↑ = increase ,↓ =decrease ,→ = no change ,↓↑ = unsure
Factor Nitrate esters-receptor blocker
Calcium-channel blockers
Wall Tenson 室壁张力 ↓ ± ↓
LV volume心室容量 ↓ ↑ ±
Ventricularpressure 心室压力
↓ ↓ ↓
rate 心 率 ↑ ↓ ±
contractility 收缩性 ↑ ↓ ±
心内膜 / 心外膜 blood ratio 血流比率
↑ ↑ ↑
the flow of side branch 侧枝血流 ↑ → ↑
end